Identi Healthcare (XTAE:IDNT) Research & Development: ₪ Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:IDNT Identi Healthcare Ltd XTAE:IDNT
25 GF Score
Price ₪1.76
! 1 Warning Sign
View Full Analysis

What is Identi Healthcare Research & Development?

Identi Healthcare XTAE:IDNT 25 Research & Development is ₪ Mil as of . 20. GuruFocus rates XTAE:IDNT with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Identi Healthcare's Research & Development for the six months ended in . 20 was ₪0.00 Mil. Identi Healthcare does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Identi Healthcare  (XTAE:IDNT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Identi Healthcare Research & Development Related Terms

Identi Healthcare Research & Development Historical Data

* Premium members only.

The historical data trend for Identi Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Identi Healthcare Research & Development Chart

Identi Healthcare Annual Data
Trend
Research & Development

Identi Healthcare Semi-Annual Data
Research & Development
XTAE:IDNT
25GF Score
Identi Healthcare Ltd XTAE:IDNT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Identi Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₪ Mil mean?
Identi Healthcare (XTAE:IDNT) has a Research & Development of ₪ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Identi Healthcare and its competitors.
Is Identi Healthcare's Research & Development too high?
Identi Healthcare's current Research & Development is ₪ Mil. Overall, Identi Healthcare has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Identi Healthcare's Research & Development compare to VEEV and BTSG?
Identi Healthcare's Research & Development of ₪ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Identi Healthcare and its competitors. Identi Healthcare's current Research & Development is ₪ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Identi Healthcare stock overvalued right now?
Identi Healthcare (XTAE:IDNT) has a current Research & Development of ₪ Mil. The current Research & Development is ₪ Mil. Identi Healthcare's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Identi Healthcare (XTAE:IDNT), the current Research & Development is ₪ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Identi Healthcare Business Description

Address 9 Yad Harutzim Street, Poleg Industrial Zone, Building 9, P.O Box 8249, Netanya, ISR, 4250437
Identi Healthcare Ltd provides hospitals with data-capture solutions to create a real-time account of their medical inventories and consumption. The solutions offered by the company include Snap & Go, Smart Cabinet, Narcotics Cabinet, and LogiPlatform among others.
25GF Score

Get the complete analysis for XTAE:IDNT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪1.76
Price